Why is AUTL Down Today?

AUTL
$1.26
▼ -4.55% ($-0.06)
Last updated: Nov 11, 2026 8:30 PM ET

About Autolus Therapeutics plc American Depositary Share

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Sector: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Cap: $444.46M
Forward P/E: -2.8
52-Week Range: $1.12 - $2.58
Employees: 647

Overall Confidence: 65%

65% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 3.9%
This stock is significantly underperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

MODERATE VOLUME 1.3x average volume

NORMAL - This move is backed by significant volume and appears sustainable.

📍 Sector Context

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -0.6%

AUTL is outperforming its sector by -3.9%. This suggests a stock-specific catalyst.

Market Comparison

AUTL is significantly underperforming the market (-5.9% vs SPY)
S&P 500
SPY
+1.38%
Nasdaq 100
QQQ
+2.49%
AUTL
This Stock
-4.55%
vs S&P 500: -5.93%
vs Nasdaq: -7.04%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, AUTL is expected to trade between:
$1.22 - $1.29

Key Level to Watch

$1.20 support
Watch for breakdown below $1.26

🔔 Get AUTL Alerts

We'll notify you when AUTL's trend changes or a new signal fires.

Last updated: Nov 11, 2026 8:30 PM (-338 minutes ago)
Data refreshes every 30 minutes during market hours

Historical Context

AUTL has moved more than 3.0% down on 62 occasions in the past year.

54.8%
Continuation Rate
34/62 times continued down
-0.9%
Avg Next Day Change
After similar down moves
Last similar move: Nov 05, 2026 (-8.7%) → Next day: +1.6%

Frequently Asked Questions

Why is AUTL stock down today?

This stock is significantly underperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

Is AUTL stock a buy or sell right now?

Based on current analysis, AUTL shows 65% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →

What is the AUTL stock price target?

AUTL is currently trading at $1.26. Based on today's momentum, the expected short-term range is $1.22 - $1.29. See long-term price prediction →

Will AUTL stock continue falling?

Our analysis shows a 45% probability that AUTL's move continues in the next 1-3 days. Key level to watch: $1.20 (support).

Is AUTL stock oversold or overbought?

AUTL's RSI (Relative Strength Index) is currently at 28.9. This indicates oversold conditions - the stock may be due for a bounce as selling pressure appears exhausted.

What is the momentum for AUTL stock?

AUTL's 10-day momentum indicator is at -0.37. Negative momentum - the stock has mild downward pressure which may continue short-term.

Is AUTL outperforming or underperforming the market?

AUTL (-4.55%) is currently significantly underperforming the market (-5.9% vs SPY). Today, the S&P 500 (SPY) is up 1.38%, and Nasdaq (QQQ) is up 2.49%.

What does MACD indicate for AUTL?

AUTL's MACD (-0.14) is currently below the signal line (-0.12), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 37.8) is strong.

Is AUTL in an uptrend or downtrend?

Based on moving average analysis, AUTL is in a bearish trend. The price ($1.26) is trading below both the 20-day SMA ($1.49) and 50-day SMA ($1.74). This alignment typically indicates sustained downward pressure.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL